Pregabalin Capsule
Product Images NDC 71335-1758

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1758). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351758)

This appears to be information on a medication called "Lyrica 75mg (CV)" that comes in capsule form and is produced by Alkem Laboratories Ltd. The package has been labeled and packaged by someone named Bryant Ranck under the name "Prepack". The package contains 30 capsules, and the expiration date is listed as MM/YY. The NDC number for the medication is 7133517581. The package should be stored at room temperature between 20°-25°C (68°-77°F), and it is important to keep all medication out of reach of children. The last number sequence (08196301523487) is unclear and may not be relevant to the description.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

This appears to be a formula or calculation for estimating creatinine clearance (CLCr) based on age, weight, and serum creatinine levels. However, as there are no units or further context provided, it is difficult to determine the exact purpose or meaning of the formula. Therefore, more information is required to provide a useful description.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

The text is describing some data in the form of a table, which includes four different studies (P Study, E1, Study E3, and Faon) and different values for percentages and mg/days for placebo and medication dosages. There is a mention of "statistically significant" results for one of the medications compared to placebo.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This text provides a chart of different doses of Pregabalin and their respective improvement in pain from baseline. The primary measure is a percentage of the patients who improved, and the maximum improvement percentage was seen in the group taking a 600mg daily dose of Pregabalin.*

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.